Cargando…
Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
Autores principales: | Chang, Tianli, Song, Su, Huang, Donghui, Su, Ping, Xiao, Xianjin, Li, Honggang, Liao, Aihua, Xiang, Wenpei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778486/ https://www.ncbi.nlm.nih.gov/pubmed/33389097 http://dx.doi.org/10.1007/s00404-020-05829-3 |
Ejemplares similares
-
Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
por: Cavalcante, Marcelo Borges, et al.
Publicado: (2020) -
Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
por: An, Ping, et al.
Publicado: (2020) -
Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
por: Zhao, Liang, et al.
Publicado: (2021) -
The novel coronavirus outbreak in Wuhan, China
por: Zhu, Hengbo, et al.
Publicado: (2020) -
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
por: Liu, Weiyong, et al.
Publicado: (2020)